Log in
RegisterFlexibility [Regulatives / Guidelines]
Hi Helmut,
The European generic industry looks for legal certainty and does not like "flexibility". They want to stick to fixed and transparent rules in order to evaluate the risks and to assess the efforts and time to spend for a certain project. What you call "flexibility" is the reason why companies refrain from conducting studies in Russia. You could translate flexibility also by discretion, intransparancy and helplessness.
Russia is a very big and interesting market. Guess why so few generic companies try to enter this market.
Kind regards
Dan
The European generic industry looks for legal certainty and does not like "flexibility". They want to stick to fixed and transparent rules in order to evaluate the risks and to assess the efforts and time to spend for a certain project. What you call "flexibility" is the reason why companies refrain from conducting studies in Russia. You could translate flexibility also by discretion, intransparancy and helplessness.
Russia is a very big and interesting market. Guess why so few generic companies try to enter this market.
Kind regards
Dan
—
Kind regards and have a nice day
Dr_Dan
Kind regards and have a nice day
Dr_Dan
Complete thread:
- Russia Guidance – BE Karthikeyan 2013-09-02 05:55 [Regulatives / Guidelines]
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- Russia Guidance – BE drgunasakaran1 2013-09-02 06:14
- Russia Guidance – BE Karthikeyan 2013-09-02 06:21
- Russia: Toxicity data required Helmut 2013-09-02 10:31
- Russia: Toxicity data required mittyri 2013-09-02 14:18
- Russia: Toxicity data required Karthikeyan 2013-09-03 08:48
- Russia: Toxicity data required mittyri 2013-09-03 09:26
- Toxicity data: why? Helmut 2013-09-03 13:02
- Russia: Toxicity data required Karthikeyan 2013-09-04 06:46
- Russia: Toxicity data required mittyri 2013-09-04 08:58
- Federal Law # 61–FZ “On circulation of drugs” Helmut 2013-09-05 00:09
- Federal Law # 61–FZ “On circulation of drugs” Karthikeyan 2013-09-05 13:52
- # 61–FZ adopted 24 March 2010 Helmut 2013-09-05 15:21
- # 61–FZ adopted 24 March 2010 Karthikeyan 2013-09-06 06:32
- # 61–FZ adopted 24 March 2010 mittyri 2013-09-06 07:22
- # 61–FZ adopted 24 March 2010 Karthikeyan 2013-09-06 06:32
- # 61–FZ adopted 24 March 2010 Helmut 2013-09-05 15:21
- Federal Law # 61–FZ “On circulation of drugs” Karthikeyan 2013-09-05 13:52
- Federal Law # 61–FZ “On circulation of drugs” Helmut 2013-09-05 00:09
- Russia: Toxicity data required mittyri 2013-09-04 08:58
- Russia: Toxicity data required mittyri 2013-09-03 09:26
- Russia: Toxicity data required Karthikeyan 2013-09-03 08:48
- Russia: Toxicity data required mittyri 2013-09-02 14:18
- Russia: Toxicity data required Helmut 2013-09-02 10:31
- Russia Guidance – BE Karthikeyan 2013-09-02 06:21
- Russia Guidance – BE Dr_Dan 2013-09-03 14:40
- Russia Guidance – BE Helmut 2013-09-03 14:45
- Russia Guidance – BE Dr_Dan 2013-09-03 19:27
- ги́бкость Helmut 2013-09-03 21:16
- FlexibilityDr_Dan 2013-09-04 10:20
- Cultural ∆ Helmut 2013-09-04 14:30
- FlexibilityDr_Dan 2013-09-04 10:20
- Russia Guidance – BE mittyri 2013-09-04 09:15
- ги́бкость Helmut 2013-09-03 21:16
- Russia Guidance – BE Dr_Dan 2013-09-03 19:27
- Russia Guidance – BE Helmut 2013-09-03 14:45
- Russia Guidance – BE drgunasakaran1 2013-09-02 06:14
Ing. Helmut Schütz